Patients with tuberculosis in Bolivia: why do they die?

The objective of this research was to analyze why patients with tuberculosis (TB) die and to evaluate whether there are factors contributing to their fatal outcome that could be corrected. A cross-sectional observational study was conducted of the patients with active TB or its sequelae admitted to...

Full description

Bibliographic Details
Main Author: Ollé-Goig Jaime E.
Format: Article
Language:English
Published: Pan American Health Organization 2000-01-01
Series:Revista Panamericana de Salud Pública
Online Access:http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892000000800001
id doaj-240184d5b3154c22a2682c80d14e0aae
record_format Article
spelling doaj-240184d5b3154c22a2682c80d14e0aae2020-11-24T22:04:18ZengPan American Health OrganizationRevista Panamericana de Salud Pública1020-49892000-01-0183151155Patients with tuberculosis in Bolivia: why do they die?Ollé-Goig Jaime E.The objective of this research was to analyze why patients with tuberculosis (TB) die and to evaluate whether there are factors contributing to their fatal outcome that could be corrected. A cross-sectional observational study was conducted of the patients with active TB or its sequelae admitted to the TB ward of the main public hospital in the city of Santa Cruz, Bolivia, over a 29-month period, from October 1993 through February 1996. The available records of the patients who died during hospitalization were reviewed. Out of 597 patients, 94 of them (15.7%) died. We examined the records of 90 of these 94 patients. Their mean age was 35.1 years (standard deviation, 16.7 years), and 45 of the patients (50.0%) were male. On admission 42 of the 90 patients (46.7%) had never been treated for TB or had received anti-TB treatment for less than one month, 23 (25.6%) had returned after having abandoned their TB treatment, 8 (8.9%) had had an erroneous diagnosis, 6 (6.7%) had tuberculosis sequelae, 6 (6.7%) were undergoing tuberculosis treatment, and 5 (5.6%) were known to have multidrug-resistant TB. Of the 90 patients, 83 (92.2%) had pulmonary tuberculosis (median lobes affected, 4), 6 (6.7%) had pleural tuberculosis, and 12 (13.3%) had extrapulmonary tuberculosis (some patients had more than one form of TB). Patients died a median of 5.5 days after entering the TB ward. The causes of death were: hemoptysis, 6 patients (6.7%); other tuberculosis-related causes, 65 patients (72.2%); drug reactions, 6 patients (6.7%); nontuberculosis causes, 6 patients (6.7%); and undetermined causes, 7 patients (7.8%). Factors possibly contributing to death were late diagnosis (38.9%), errors in follow-up (14.4%), and errors in treatment (24.4%). In conclusion, most patients with active or inactive TB admitted to our ward died as a consequence of tuberculosis. There were several factors possibly contributing to their fatal outcome that could be corrected.http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892000000800001
collection DOAJ
language English
format Article
sources DOAJ
author Ollé-Goig Jaime E.
spellingShingle Ollé-Goig Jaime E.
Patients with tuberculosis in Bolivia: why do they die?
Revista Panamericana de Salud Pública
author_facet Ollé-Goig Jaime E.
author_sort Ollé-Goig Jaime E.
title Patients with tuberculosis in Bolivia: why do they die?
title_short Patients with tuberculosis in Bolivia: why do they die?
title_full Patients with tuberculosis in Bolivia: why do they die?
title_fullStr Patients with tuberculosis in Bolivia: why do they die?
title_full_unstemmed Patients with tuberculosis in Bolivia: why do they die?
title_sort patients with tuberculosis in bolivia: why do they die?
publisher Pan American Health Organization
series Revista Panamericana de Salud Pública
issn 1020-4989
publishDate 2000-01-01
description The objective of this research was to analyze why patients with tuberculosis (TB) die and to evaluate whether there are factors contributing to their fatal outcome that could be corrected. A cross-sectional observational study was conducted of the patients with active TB or its sequelae admitted to the TB ward of the main public hospital in the city of Santa Cruz, Bolivia, over a 29-month period, from October 1993 through February 1996. The available records of the patients who died during hospitalization were reviewed. Out of 597 patients, 94 of them (15.7%) died. We examined the records of 90 of these 94 patients. Their mean age was 35.1 years (standard deviation, 16.7 years), and 45 of the patients (50.0%) were male. On admission 42 of the 90 patients (46.7%) had never been treated for TB or had received anti-TB treatment for less than one month, 23 (25.6%) had returned after having abandoned their TB treatment, 8 (8.9%) had had an erroneous diagnosis, 6 (6.7%) had tuberculosis sequelae, 6 (6.7%) were undergoing tuberculosis treatment, and 5 (5.6%) were known to have multidrug-resistant TB. Of the 90 patients, 83 (92.2%) had pulmonary tuberculosis (median lobes affected, 4), 6 (6.7%) had pleural tuberculosis, and 12 (13.3%) had extrapulmonary tuberculosis (some patients had more than one form of TB). Patients died a median of 5.5 days after entering the TB ward. The causes of death were: hemoptysis, 6 patients (6.7%); other tuberculosis-related causes, 65 patients (72.2%); drug reactions, 6 patients (6.7%); nontuberculosis causes, 6 patients (6.7%); and undetermined causes, 7 patients (7.8%). Factors possibly contributing to death were late diagnosis (38.9%), errors in follow-up (14.4%), and errors in treatment (24.4%). In conclusion, most patients with active or inactive TB admitted to our ward died as a consequence of tuberculosis. There were several factors possibly contributing to their fatal outcome that could be corrected.
url http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892000000800001
work_keys_str_mv AT ollegoigjaimee patientswithtuberculosisinboliviawhydotheydie
_version_ 1725829490985140224